Detalles de la búsqueda
1.
Predictors of response to axicabtagene-ciloleucel CAR T cells in aggressive B cell lymphomas: A real-world study.
J Cell Mol Med;
26(24): 5976-5983, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36453136
2.
Gender Differences in Faculty Rank and Subspecialty Choice among Academic Medical Oncologists.
Cancer Invest;
39(1): 21-24, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33131319
3.
Development and validation of the Individual Burden of Illness Index for Major Depressive Disorder (IBI-D).
Adm Policy Ment Health;
40(2): 76-86, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21969214
4.
Neutrophil to lymphocyte ratio and peripheral blood biomarkers correlate with survival outcomes but not response among head and neck and salivary cancer treated with pembrolizumab and vorinostat.
Head Neck;
45(2): 391-397, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36412064
5.
GFAP and NfL increase during neurotoxicity from high baseline levels in pediatric CD19-CAR T-cell patients.
Blood Adv;
7(6): 1001-1010, 2023 03 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36006611
6.
Peripheral lymphocytes and lactate dehydrogenase correlate with response and survival in head and neck cancers treated with immune checkpoint inhibitors.
Cancer Med;
12(8): 9384-9391, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36806947
7.
Anakinra for Refractory Cytokine Release Syndrome or Immune Effector Cell-Associated Neurotoxicity Syndrome after Chimeric Antigen Receptor T Cell Therapy.
Transplant Cell Ther;
29(7): 430-437, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37031746
8.
Hematopoietic Cell Transplantation after CD19 Chimeric Antigen Receptor T Cell-Induced Acute Lymphoblastic Lymphoma Remission Confers a Leukemia-Free Survival Advantage.
Transplant Cell Ther;
28(1): 21-29, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34644605
9.
Severe cytokine release syndrome is associated with hematologic toxicity following CD19 CAR T-cell therapy.
Blood Adv;
6(7): 2055-2068, 2022 04 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34666344
10.
High End-of-Life Health Care Utilization in a Contemporary Cohort of Head and Neck Cancer Patients Treated with Immune Checkpoint Inhibitors.
J Palliat Med;
25(4): 614-619, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34847733
11.
Performance status (PS) as a predictor of poor response to immune checkpoint inhibitors (ICI) in recurrent/metastatic head and neck cancer (RMHNSCC) patients.
Cancer Med;
11(22): 4104-4111, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35349227
12.
Predictors of cytopenias after treatment with axicabtagene ciloleucel in patients with large B-cell lymphoma.
Leuk Lymphoma;
63(12): 2918-2922, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35811554
13.
Modified Manufacturing Process Modulates CD19CAR T-cell Engraftment Fitness and Leukemia-Free Survival in Pediatric and Young Adult Subjects.
Cancer Immunol Res;
10(7): 856-870, 2022 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35580141
14.
Inaccessible LCG Promoters Act as Safeguards to Restrict T Cell Development to Appropriate Notch Signaling Environments.
Stem Cell Reports;
16(4): 717-726, 2021 04 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33770495
15.
Ibrutinib Monotherapy in Relapsed or Refractory, Transformed Diffuse Large B-cell Lymphoma.
Clin Lymphoma Myeloma Leuk;
21(3): 176-181, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33358575
16.
Space-log: a novel approach to inferring gene-gene net-works using SPACE model with log penalty.
F1000Res;
9: 1159, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-35083040
17.
A Phase II Trial of Pembrolizumab and Vorinostat in Recurrent Metastatic Head and Neck Squamous Cell Carcinomas and Salivary Gland Cancer.
Clin Cancer Res;
26(4): 837-845, 2020 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31796519
18.
Impact of region of diagnosis, ethnicity, age, and gender on survival in acute myeloid leukemia (AML).
J Drug Assess;
7(1): 51-53, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30034924
19.
Prospective Study of Serial 18F-FDG PET and 18F-Fluoride PET to Predict Time to Skeletal-Related Events, Time to Progression, and Survival in Patients with Bone-Dominant Metastatic Breast Cancer.
J Nucl Med;
59(12): 1823-1830, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29748233
Resultados
1 -
19
de 19
1
Próxima >
>>